Phase 1 Study of Tremelimumab, Durvalumab, High-dose Chemotherapy, + Autologous Stem Cell Transplant
Clinical trial NCT02716805 · TERMINATED
Trial details
- NCT number
- NCT02716805
- Sponsor
- Ludwig Institute for Cancer Research
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-12-13
- Primary completion
- 2018-02-16
- Enrollment
- 6
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.